Results 71 to 80 of about 10,251 (261)
Midostaurin in daily clinical practice of patients with advanced systemic mastocytosis
Durable responses based on modified Valent, IWG‐MRT‐ECNM and PPR criteria were predominantly dose‐independent, making dose adjustments due to better tolerability more practicable in daily routine. Gradual tapering of midostaurin, prophylactic treatment with antihistamines and corticosteroids and timely initiation of subsequent therapy can prevent a ...
Johannes Lübke +10 more
wiley +1 more source
Pharmacogenetics and personalized medicine : does gender have a role? [PDF]
The study of the role of genetic polymorphisms in drug responses, is now a firmly established field of pharmacology research. It has robust applications in predicting drug effect, and therefore contributes to the process of optimum selection of drug and ...
Fenech, Anthony G., Grech, Godfrey
core
Aszites, Pfortaderthrombose und hepatische Enzephalopathie bei Leberzirrhose: Aktuelle Therapieempfehlungen [PDF]
Treatment of Ascites, Portal Vein Thrombosis and Hepatic Encephalopathy in Patients with Cirrhosis of the Liver Background: Ascites, portal vein thrombosis and hepatic encephalopathy are important complications of cirrhosis of the liver.
Abecasis R +46 more
core +1 more source
DIURETICS IN THE TREATMENT OF CHRONIC HEART FAILURE: FUROSEMIDE OR TORASEMIDE (LITERATURE REVIEW)
Optimization of diuretic therapy in patients with chronic heart failure (CHF) is a complex problem with many unsolved questions. Diuretics play an important role in the treatment of heart failure. Current guidelines recommend using loop diuretics for the
S. Biletskyi +5 more
semanticscholar +1 more source
Urine specimens represent the gold standard for screening analyses in forensic toxicology but are not always available postmortem. The current study systematically evaluated bladder wash (BW) as an interesting, but largely unexplored specimen for screening, in comparison to urine and kidney tissue (KT).
Andrea E. Steuer +4 more
wiley +1 more source
To study the association of gene polymorphism CYP2С9*2 (rs1799853, c.430C>T, Arg144Cys), CYP2C9*3 (rs1057910, 1075A>C, Ile359Leu) and SLCO1B1*5 (rs4149056, c.521T>C, Val174Ala) with an effective dose of torasemide in patients with chronic heart failure ...
N. Gafurova +3 more
semanticscholar +1 more source
ABSTRACT Background Placement of a transjugular intrahepatic portosystemic shunt (TIPS) is an effective treatment for portal hypertension. Overt hepatic encephalopathy (oHE) is a complication after TIPS associated with increased morbidity. Elevated ratio of plasma ammonia (AMM) levels compared to the local upper limit of normal (ULN) has been ...
Lisa Sandmann +10 more
wiley +1 more source
Exploring safety of down‐titrating diuretics in heart failure management
Event probabilities following down‐titration (), up‐titration (), or no dose change (=). One person represents approximately 10% of cases. Abstract Aims Loop diuretics are widely used in heart failure (HF) for symptom relief. Guidelines advise treating patients with the lowest possible dose of loop diuretics to maintain euvolaemia, based on expert ...
Chrit B.G. Geraeds +5 more
wiley +1 more source
The potential toxicity of loop diuretics in patients with cardiovascular complications
A patient with cardiovascular complications is a proper candidate for a diuretic treatment. Here, loop diuretics are the drugs with the greatest strength and time of acting, especially when used in urgent cases like exacerbation of heart failure is ...
Grzegorz Liczner +5 more
doaj +3 more sources
Sacubitril/valsartan reduces serum uric acid concentration, an independent predictor of adverse outcomes in PARADIGM-HF [PDF]
Aims: Elevated serum uric acid concentration (SUA) has been associated with an increased risk of cardiovascular disease, but this may be due to unmeasured confounders.
Chen, Chen-Huan +16 more
core +3 more sources

